267 related articles for article (PubMed ID: 35303250)
61. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
62. Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses.
Haan E; Sallis HM; Zuccolo L; Labrecque J; Ystrom E; Reichborn-Kjennerud T; Andreassen O; Havdahl A; Munafò MR
Addiction; 2022 May; 117(5):1458-1471. PubMed ID: 34791750
[TBL] [Abstract][Full Text] [Related]
63. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort.
Zhu JL; Olsen J; Liew Z; Li J; Niclasen J; Obel C
Pediatrics; 2014 Aug; 134(2):e382-8. PubMed ID: 25049343
[TBL] [Abstract][Full Text] [Related]
64. The role of birth weight on the causal pathway to child and adolescent ADHD symptomatology: a population-based twin differences longitudinal design.
Lim KX; Liu CY; Schoeler T; Cecil CAM; Barker ED; Viding E; Greven CU; Pingault JB
J Child Psychol Psychiatry; 2018 Oct; 59(10):1036-1043. PubMed ID: 29999186
[TBL] [Abstract][Full Text] [Related]
65. Prenatal exposure to maternal and paternal smoking on attention deficit hyperactivity disorders symptoms and diagnosis in offspring.
Nomura Y; Marks DJ; Halperin JM
J Nerv Ment Dis; 2010 Sep; 198(9):672-8. PubMed ID: 20823730
[TBL] [Abstract][Full Text] [Related]
66. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.
Linnet KM; Dalsgaard S; Obel C; Wisborg K; Henriksen TB; Rodriguez A; Kotimaa A; Moilanen I; Thomsen PH; Olsen J; Jarvelin MR
Am J Psychiatry; 2003 Jun; 160(6):1028-40. PubMed ID: 12777257
[TBL] [Abstract][Full Text] [Related]
67. Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood.
Ji Y; Azuine RE; Zhang Y; Hou W; Hong X; Wang G; Riley A; Pearson C; Zuckerman B; Wang X
JAMA Psychiatry; 2020 Feb; 77(2):180-189. PubMed ID: 31664451
[TBL] [Abstract][Full Text] [Related]
68. Are congenital heart defects connected to more severe attention-deficit/hyperactivity disorder?: A systematic review and meta-analysis.
Hasan MT; Shaban Abdelgalil M; Elbadawy MA; Mahmoud Elrosasy A; Elkhadragy A; El Garhy M; Awad AK
Medicine (Baltimore); 2023 Nov; 102(47):e36193. PubMed ID: 38013322
[TBL] [Abstract][Full Text] [Related]
69. Organophosphate pesticide metabolite concentrations in urine during pregnancy and offspring attention-deficit hyperactivity disorder and autistic traits.
van den Dries MA; Guxens M; Pronk A; Spaan S; El Marroun H; Jusko TA; Longnecker MP; Ferguson KK; Tiemeier H
Environ Int; 2019 Oct; 131():105002. PubMed ID: 31369979
[TBL] [Abstract][Full Text] [Related]
70. Attention-Deficit/Hyperactivity Disorder and Very Preterm/Very Low Birth Weight: A Meta-analysis.
Franz AP; Bolat GU; Bolat H; Matijasevich A; Santos IS; Silveira RC; Procianoy RS; Rohde LA; Moreira-Maia CR
Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29255083
[TBL] [Abstract][Full Text] [Related]
71. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
[TBL] [Abstract][Full Text] [Related]
72. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
73. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
[TBL] [Abstract][Full Text] [Related]
74. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
75. Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis.
Maher GM; O'Keeffe GW; Kearney PM; Kenny LC; Dinan TG; Mattsson M; Khashan AS
JAMA Psychiatry; 2018 Aug; 75(8):809-819. PubMed ID: 29874359
[TBL] [Abstract][Full Text] [Related]
76. Apgar Scores Are Associated with Attention-Deficit/Hyperactivity Disorder Symptom Severity.
Grizenko N; Eberle ML; Fortier ME; Côté-Corriveau G; Jolicoeur C; Joober R
Can J Psychiatry; 2016 May; 61(5):283-90. PubMed ID: 27254803
[TBL] [Abstract][Full Text] [Related]
77. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
[TBL] [Abstract][Full Text] [Related]
78. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
79. Correspondence of parent report and laboratory measures of inattention and hyperactivity in children with heavy prenatal alcohol exposure.
Glass L; Graham DM; Deweese BN; Jones KL; Riley EP; Mattson SN
Neurotoxicol Teratol; 2014; 42():43-50. PubMed ID: 24512965
[TBL] [Abstract][Full Text] [Related]
80. New-generation antiepileptic drugs during pregnancy and the risk of attention-deficit hyperactivity disorder: A scoping review.
Vaccaro C; Shakeri A; Czaplinski E; Eltonsy S
J Popul Ther Clin Pharmacol; 2020; 27(4):e1-e18. PubMed ID: 33084259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
